092040 — Amicogen Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩192bn
Enterprise Value
KR₩294bn
Revenue
KR₩174bn

Annual balance sheet for Amicogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	44,011	42,546	23,694	31,532	9,041
Net Total Accounts Receivable
Net Total Receivables	18,506	33,169	59,061	62,506	66,428
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	110,346	123,659	143,947	156,063	87,873
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	88,037	139,250	173,076	228,036	165,858
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	283,368	411,224	429,652	467,098	294,227
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	70,879	160,470	205,169	174,883	99,280
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	130,427	225,060	297,855	291,256	171,732
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	152,941	186,164	131,797	175,842	122,495
Total Liabilities & Shareholders' Equity	283,368	411,224	429,652	467,098	294,227
Total Common Shares Outstanding